Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:EARS
Delisted

Auris Medical Holding AG Stock Price (Quote)

$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.680 $1.00 Friday, 27th May 2022 EARS stock ended at $0.750. This is 0.133% less than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 10.68% from a day low at $0.740 to a day high of $0.82.
90 days $0.635 $2.14
52 weeks $0.635 $4.58

Historical Auris Medical Holding AG prices

Date Open High Low Close Volume
Sep 30, 2016 $1.74 $1.76 $1.71 $1.73 66 700
Sep 29, 2016 $1.75 $1.79 $1.71 $1.74 88 300
Sep 28, 2016 $1.76 $1.78 $1.71 $1.76 169 100
Sep 27, 2016 $1.70 $1.78 $1.69 $1.73 169 800
Sep 26, 2016 $1.72 $1.77 $1.66 $1.70 126 600
Sep 23, 2016 $1.80 $1.80 $1.68 $1.71 144 800
Sep 22, 2016 $1.68 $1.76 $1.66 $1.76 311 700
Sep 21, 2016 $1.66 $1.69 $1.63 $1.63 231 700
Sep 20, 2016 $1.63 $1.70 $1.61 $1.65 157 000
Sep 19, 2016 $1.70 $1.72 $1.62 $1.67 181 200
Sep 16, 2016 $1.66 $1.70 $1.60 $1.67 414 500
Sep 15, 2016 $1.65 $1.68 $1.60 $1.65 190 800
Sep 14, 2016 $1.74 $1.75 $1.61 $1.64 310 400
Sep 13, 2016 $1.76 $1.78 $1.66 $1.69 366 100
Sep 12, 2016 $1.92 $1.92 $1.65 $1.68 952 000
Sep 09, 2016 $1.71 $1.97 $1.70 $1.82 3 526 000
Sep 08, 2016 $1.66 $1.66 $1.55 $1.58 606 000
Sep 07, 2016 $1.64 $1.66 $1.62 $1.64 249 100
Sep 06, 2016 $1.67 $1.70 $1.62 $1.65 791 000
Sep 02, 2016 $1.73 $1.79 $1.65 $1.71 311 900
Sep 01, 2016 $1.80 $1.84 $1.70 $1.71 1 039 500
Aug 31, 2016 $1.98 $1.98 $1.82 $1.85 567 900
Aug 30, 2016 $2.01 $2.04 $1.96 $1.98 456 200
Aug 29, 2016 $2.06 $2.06 $2.01 $2.03 249 600
Aug 26, 2016 $2.03 $2.09 $1.97 $2.07 629 200
Click to get the best stock tips daily for free!

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... EARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT